Сайт предназначен для врачей
Поиск:

 

Список литературы

1.    Rihal C.S. et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259–2264.

2.    From A. M. et al. Mortality Associated With Nephropathy After Radiographic Contrast Exposure. Mayo. Clin. Proc. 2008; 83 (10):1095–1100.

3.    Aspelin P. et al. Nephrotoxic effects in highrisk patients undergoing angiography. N. Engl. J. Med. 2003; 348: 491–499.

4.    McCullough P.A. et al. A Meta-Analysis of the Renal Safety of Isosmolar Iodixanol Compared With Low-Osmolar Contrast Media. J. of the Amer. Col. of Card. 2006; 48: 4.

5.    Aspelin P. et al. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy. Am. Heart. J. 2005; 149: 298–303.

6.    Solomon R.J. et al. Cardiac Angiography in Renally Impaired Patients (CARE) study. А randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007; 115:3189 –3196.

7.    Rudnick M.R. et al. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease. Тhe VisipaqueAngiography. Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. Am. Heart.J. 2008; 156: 776–782.

8.    Thomsen H.S. et al. The ACTIVE Tria. Сomparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest. Radiol. 2008; 43: 170–178.

9.    Kuhn M.J. et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. AJR. 2008; 191:151–157.

10.  Barrett B.J. et al. Contrastinduced nephropathy in patients with chronic kidney disease undergoing computed tomography. А double-blind comparisonof iodixanol and iopamidol. Invest. Radiol. 2006; 41: 815–821.

11.  Liss P. et al. Renal failure in 57 925 patients undergoing coronary procedures using isoosmolar or low-osmolar contrast media. Kidney International (2006) 70, 1811–1817.

12.  Per Liss, Uppsala University, Sweden RSNA 2008 SSG08-01. Higher Incidence of Renal Failure in 23,224 Patients Using Iso-osmolar Compared to Low-osmolar Contrast Media during Coronary Interventions in Swedish Hospitals. From A.M. et al. Iodixanol compared to iohexol for contrast procedures. А case-matched retrospective cohort study. Acta. Radiol. 2008; 49: 409–414.

13.  Heinrich M. C. et al. Nephrotoxicity of Isoosmolar Iodixanol Compared with Nonionic Low-osmolar Contrast Media. Meta-analysis of Randomized Controlled Trials. Radiology.2009; 1: 250.

14.  Reed M. et al. The Relative Renal Safety of Iodixanol Compared With Low-Osmolar Contrast Media. A Meta-Analysis of Randomized Controlled Trials. JACC: Сardiovasc. Intervent. 2009; 2 (7): 645–654.

15.  Sharma S.K. Iodinated Contrast Media and Contrast-Induced Nephropathy. Is There a Preferred Cost-Effective Agent? J. Invasс. Cardiol. 2008; 20: 245–248. Межрегиональная общественная организация «Общество фармакоэкономических исследований» «Справедливость. Качество. Экономичность». URL: http://www.rspor.ru/index.php?mod1=congress/rspor09ppt

16.  Solomon R.S., DuMouchel W. Contrast Media and Nephropathy. Findings From Systematic Analysis and Food and Drug Administration Reports of Adverse Effects. Invest. Radiol. 2006; 41: 651–660.

17.  Feldkamp T. et al.: Nephrotoxicity of isoosmolar versus low osmolar contrast media is equal in low risk patients. Clin. Nephrol. 2006; 66: 322–330.

18.  Carraro M. et al. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency. А double-blind, randomized clinical trial. Eur. Radiol. 1998; 8:144–147.

19.  Manninen H. et al. Iodixanol, a new non-ionic, dimeric contrast medium in cardioangiography. А double-masked, parallel comparison with iopromide. Eur. Radiol.1995; 5: 364–370.

20.  Pugh N.D. et al. Iodixanol in femoral arteriography (phase III). А comparative double-blind parallel trial between iodixanol and iopromide. Clin. Radiol. 1993; 47: 96–99.

21.  Juergens C.P. et al. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetyl-cysteine and hydration before coronary angiography and intervention. А randomized trial.Inter. Medic. J. 2009; 39; 25–31.

22. Ngyuen S.A. et al. Iso-Osmolality versus Low-Osmolality Iodinated Contrast Medium at Intravenous Contrast-enhanced CT. Effect on Kidney Function. Radiology. 2008; 1 (7): 248.

23.  Nie B. et al. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Cathet.Card. Interv. 2008; 72 (7): 958–965.

24.  Kushner F.G. et al. 2009 Focused updates. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guide-lines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). А report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009; 120: 2271–2306.

25.  Hanninen E.L. et al. Detection of focal liver lesions at biphasic spiral CT. Randomized double-blind study of the effect of iodine concentration in contrast materials. Radiology. 2000; 216 (2): 403–409.

 


Импакт-фактор elibrary:
0,181

ANGIOLOGIA.ru (АНГИОЛОГИЯ.ру) - портал о диагностике и лечении заболеваний сосудистой системы